On August 16, 2026, MEBO Group celebrated its 39th anniversary with the inauguration of the new Shantou MEBO Pharmaceutical facility, marking a new chapter in the Group’s regenerative medicine journey. 

At the inauguration ceremony, MEBO Group Board Director Li Li reflected on the Group’s development and expressed confidence in its continued growth rooted in Shantou. Dong Hai, General Manager of Shantou MEBO Pharmaceutical, highlighted the new facility’s strategic role and capabilities.

The ceremony featured a vibrant Yingge dance performance, a traditional intangible cultural heritage of Shantou, followed by the official ribbon-cutting ceremony. A statue of Professor Rongxiang Xu was also unveiled at the new facility. As the Founder of MEBO and a pioneer in regenerative medicine, Professor Xu’s enduring vision and commitment continue to inspire generations of MEBO professionals and guide the Group’s mission to advance regenerative medicine and protect human life.

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.